Filing Flows › Comparisons › MMED vs PODD
MiniMed Group vs Insulet: MMED and PODD compared
MiniMed Group is the larger company: $843M of revenue in its latest quarter (Q2 2026) against $842M for Insulet (Q3 2026). Insulet is growing faster (+19% against +17% a year earlier). Insulet is more profitable, with an operating margin of 22.5% against 0.6%.
Where the money goes: MMED and PODD
MiniMed Group (MMED) · Q2 2026
MiniMed Group, Q2 2026: revenue $843M (+17% year over year), operating margin 0.6%, net earnings $0, operating cash flow −$49.0M. The chart follows the revenue to costs, profit and cash.
Insulet (PODD) · Q3 2026
Insulet, Q3 2026: revenue $842M (+19% year over year), operating margin 22.5%, net earnings $141M, operating cash flow $124M. The chart follows the revenue to costs, profit and cash.
| MiniMed Group (MMED) | Insulet (PODD) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $843M | $842M |
| Revenue growth, Y/Y | +17% | +19% |
| Gross margin | 55.2% | 75.1% |
| Operating margin | 0.6% | 22.5% |
| Net earnings | $0 | $141M |
| Net margin | 0.0% | 16.8% |
| Operating cash flow | −$49.0M | $124M |
| Free cash flow | — | $66.4M |
| Market value | $4.7B | $10.2B |
| P/E | — | 23.9× |
| Analysts’ mean target | $25.47 | $178.35 |
Where the revenue comes from
MiniMed Group
- CGM: $431M (51%)
- Consumables: $261M (31%)
- Pumps: $144M (17%)
- Other: $7.0M (1%)
Insulet
- Total Omnipod products: $837M (99%)
- Drug Delivery: $5.5M (1%)
Questions
Which is bigger, MiniMed Group or Insulet?
MiniMed Group is the larger company: $843M of revenue in its latest quarter (Q2 2026) against $842M for Insulet (Q3 2026).
Is MiniMed Group or Insulet growing faster?
Insulet is growing faster (+19% against +17% a year earlier).
Which is more profitable, MiniMed Group or Insulet?
Insulet is more profitable, with an operating margin of 22.5% against 0.6%.
More: MiniMed Group earnings · how MiniMed Group makes money · Insulet earnings · how Insulet makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Sep 8, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.